戴维医疗最新股价为15.47元，较前一交易日上涨5.38%。开盘价为15.76元，最高触及16.95元，最低下 探至15.22元，成交量为35.23万手，成交额达5.62亿元。 戴维医疗属于医疗器械板块，公司主营业务为儿产科保育设备及微创外科手术器械的研发、生产和销 售，同时布局急救手术ICU产品。2025年上半年，公司实现营业收入2.51亿元，同比下降5.48%；归属 于上市公司股东的净利润5097.67万元，同比增长9.57%。 风险提示：投资有风险，入市需谨慎。 来源:金融界 消息面上，戴维医疗披露2025年半年度报告，显示公司净利润同比增长9.57%。此外，公司第五届监事 会第十三次会议审议通过了多项议案。 资金流向方面，戴维医疗当日主力资金净流入1585.80万元，占流通市值的0.71%。近五日主力资金净流 入963.45万元，占流通市值的0.43%。 ...

8月22日，戴维医疗今日收盘15.47元，上涨5.38%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到72.19倍，总市值44.55亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均56.95倍，行业中值40.49倍，戴维医疗排 名第95位。 股东方面，截至2025年8月20日，戴维医疗股东户数22900户，较上次增加400户，户均持股市值35.28万 元，户均持股数量2.76万股。 宁波戴维医疗器械股份有限公司的主营业务是儿产科保育设备、微创外科手术器械等产品的研发、生产 和销售。公司的主要产品是儿产科保育设备、微创外科手术器械、急救手术ICU产品。截至报告期末， 公司及子公司累计拥有专利257项，其中发明专利70项、实用新型专利138项、外观设计专利49项，计算 机软件著作权9项。 最新一期业绩显示，2025年半年报，公司实现营业收入2.51亿元，同比-5.48%；净利润5097.67万元，同 比9.57%，销售毛利率58.40%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13戴维医疗72.1977.803.7244.55亿行业平均 56.9554.955.111 ...

Group 1 - As of August 21, David Medical's stock price closed at 14.68 yuan, down 0.94% from the previous trading day, with a trading volume of 75,116 hands and a transaction amount of 111 million yuan [1] - David Medical focuses on the research, production, and sales of medical devices, with its main business covering three areas: obstetric and neonatal care equipment, minimally invasive surgical instruments, and emergency surgical ICU products. The medical device manufacturing sector accounted for 98.08% of the company's revenue in the 2024 annual report [1] - On August 21, the company announced that the fifth session of the thirteenth board of directors approved the proposal regarding the full text and summary of the 2025 semi-annual report. The semi-annual report showed that in the first half of 2025, the company achieved operating revenue of 251 million yuan, a year-on-year decrease of 5.48%, while the net profit attributable to shareholders of the listed company was 50.98 million yuan, a year-on-year increase of 9.57%. Notably, the second quarter performance was strong, with a year-on-year growth of 237.4% in net profit attributable to the parent [1] Group 2 - On August 21, David Medical saw a net inflow of main funds amounting to 2.7751 million yuan, with a cumulative net inflow of 2.1627 million yuan over the past five days [2]